Introduction: In clinical medicine, natriuretic peptides, including N-terminal B-type natriuretic peptide (NT-proBNP), are used to detect increased myocardial wall tension in conditions such as heart failure. Tachycardia, arrhythmias and physical exercise may also increase these peptides. The clinical reference value is <100 ng/l, and in clinical practice values >300 ng/l are a strong indicators of heart failure, and values >5000 ng/l highly significant for mortality within 3 months.
Methods: We examined the levels of NT-proBNP after ultra-endurance exercise, and also made an attempt to relate NT-proBNP to performance. The subjects (12 males and 3 females) participated in the Adventure Racing World Championship, a 5-6 days non-stop competition open for mixed gender team of four athletes. They were all healthy, well-trained athletes with experience from several years of competitions at international elite level. Blood samples for determination of NT-proBNP were drawn before exercise (Pre-Ex), at the end of the race (End-Ex) and 24 hours after exercise (Post-Ex). Each athlete rated his/her own performance at the end of the race (i.e. the last 12 hours) on a scale from 1 (good, stronger than teammates), 2 (intermediate) and 3 (poor, got towed in, needed help from teammates). In addition, each athlete was also rated according to the same scale by the other three members of his/her team. Thereafter the four rates were pooled. Note that the rating is in relation to the team rather than the result of the competition.
Results: The average exercise duration was approx. 150 hours, and the calculated average work intensity was 40 % (in percent of respective VO2peak), including time for rest, change of equipment, and food intake. The levels of NT-proBNP increased from 31 ± 14 (10-56) [mean ± SD (min-max)] at Pre-Ex to 487 ± 648 (52-2480) at End-Ex. At Post-Ex the corresponding levels were 224 ± 219 (12-634). At End-Ex seven subjects had NT-proBNP below the reference value. The rated performance for four of them was 1, and the remaining three were rated as 2. Three of the subjects had markedly higher levels than previously reported (>900 ng/l) and they were rated 3, 3 and 2, respectively.
Discussion: Extreme levels of NT-proBNP, up to 2500 ng/l, are present after ultra-endurance exercise in healthy athletes without any clinical signs or symptoms of heart failure. On the other hand, these extreme values may be an indicator of cardiac fatigue, previously described after endurance exercise. Furthermore, in this study high levels of NT-proBNP seem to be associated with decreased exercise performance.
2010. p. 35-36